Gilead Sciences Inc Dividends
The next dividend date for Gilead Sciences Inc is September 15, 2026.
A dividend of $0.82 per share is scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Gilead Sciences Inc (GILD)
| 06/15/2026 | 05/07/2026 | 06/15/2026 | 06/29/2026 | $0.82 |
| 03/13/2026 | 02/10/2026 | 03/13/2026 | 03/30/2026 | $0.82 |
| 12/15/2025 | 10/30/2025 | 12/15/2025 | 12/30/2025 | $0.79 |
| 09/15/2025 | 07/29/2025 | 09/15/2025 | 09/29/2025 | $0.79 |
| 06/13/2025 | 04/22/2025 | 06/13/2025 | 06/27/2025 | $0.79 |
| 03/14/2025 | 02/11/2025 | 03/14/2025 | 03/28/2025 | $0.79 |
| 12/13/2024 | 11/06/2024 | 12/13/2024 | 12/30/2024 | $0.77 |
| 09/13/2024 | 08/08/2024 | 09/13/2024 | 09/27/2024 | $0.77 |
| 06/14/2024 | 04/25/2024 | 06/14/2024 | 06/27/2024 | $0.77 |
| 03/14/2024 | 02/01/2024 | 03/15/2024 | 03/28/2024 | $0.77 |
More About Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
Owning Gilead Sciences Inc Stock on the Dividend Date
If you own Gilead Sciences Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Gilead Sciences Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Gilead Sciences Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Gilead Sciences Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Gilead Sciences Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Gilead Sciences Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Gilead Sciences Inc stock price from the dividend is already baked into Gilead Sciences Inc option prices.
That means the prices of call options that overlap the Gilead Sciences Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Gilead Sciences Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Gilead Sciences Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Gilead Sciences Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Gilead Sciences Inc Dividends
You can contact us any time if you would like to ask questions about Gilead Sciences Inc dividends or anything else related to the stock market.